Molex to acquire drug device company Vectura [Yahoo! Finance]
Philip Morris International Inc (PM)
Last philip morris international inc earnings: 4/21 06:59 am
Check Earnings Report
US:NYSE Investor Relations:
pmi.com/investor-relations/overview
Company Research
Source: Yahoo! Finance
This acquisition from Vectura Fertin Pharma, a subsidiary of Philip Morris International, is expected to enhance the capabilities of Phillips Medisize, a Molex company, by bringing in specialised inhalation expertise. Phillips Medisize president Paul Chaffin said: “Combining the strengths of Phillips Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical customers and support our mission to help people live healthier, more productive lives.” Vectura is involved in the formulation and device development of dry powder inhalers (DPI), pressurised metered-dose inhalers (pMDI), and nasal and nebuliser products for biologics, small molecules, complex combinations, and generic products. The acquisition also encompasses Vectura's services in pharmaceutical analysis, process development, technical transfer, clinical trial supplies, and regulatory services. Molex CEO Joe Nelligan said: “The
Show less
Read more
Impact Snapshot
Event Time:
PM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PM alerts
High impacting Philip Morris International Inc news events
Weekly update
A roundup of the hottest topics
PM
News
- Philip Morris International Inc. (NYSE: PM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $126.00 to $140.00. They now have a "buy" rating on the stock.MarketBeat
- How Zyn Took Over America [Forbes]Forbes
- Philip Morris plays defense against Tucker Carlson [Seeking Alpha]Seeking Alpha
- Billionaire Stanley Druckenmiller Just Added This Hot Dividend Growth Stock to His Portfolio [Yahoo! Finance]Yahoo! Finance
- Marlboro owner sells UK inhaler firm over backlash [Yahoo! Finance]Yahoo! Finance
PM
Earnings
- 7/23/24 - Beat
PM
Sec Filings
- 9/17/24 - Form 8-K
- 9/12/24 - Form 8-K
- 9/3/24 - Form 8-K
- PM's page on the SEC website